An interventional study of Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy. in Aneurysm Cerebral, sponsored by Jacobs institute. Not yet recruiting at 1 site in United States. Open to participants aged 22 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-12.
Sponsored by Jacobs institute · Not applicable, Interventional, and Treatment
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.
The FAST study is an Early Feasibility Study (EFS), prospective, open-label, single-arm, unblinded, fifteen (n=15) patient investigation
418 studies on the registry are indexed under Intracranial Aneurysm; 119 are open to participants now.
This study's planned enrollment of 15 is below the median of 100 across 207 interventional studies indexed under Intracranial Aneurysm.
Browse Intracranial Aneurysm studies →Jacobs institute is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.
medial device intervention for aneurysm cerebral.
A thromboembolic event in the territory supplied by the treated artery.
A thromboembolic event in the territory supplied by the treated artery.
Time frame: 12 months
Plan to share: Undecided — It is currently undecided.
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jacobs institute